Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study
Sponsor: Peking University Shenzhen Hospital
Summary
The aim of this study was to compare the effect-site target concentration (including EC₅₀ and EC₉₀) of remifentanil required to suppress cardiovascular responses to tracheal intubation during anesthesia induction with etomidate combined with either lidocaine or sufentanil.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
99
Start Date
2025-08-01
Completion Date
2026-07-30
Last Updated
2025-09-22
Healthy Volunteers
No
Conditions
Interventions
Intravenous normal saline (NS 0.9)
Under target-controlled infusion (TCI) of remifentanil, anesthesia induction is performed using placebo (normal saline) combined with etomidate (0.3 mg/kg).
intravenous sufentanil
Under target-controlled infusion (TCI) of remifentanil, anesthesia induction is performed using sufentanil (0.2μg/kg) combined with etomidate (0.3 mg/kg).
Intravenous lidocaine
Under target-controlled infusion (TCI) of remifentanil, anesthesia induction is performed using lidocaine (1.5 mg/kg) combined with etomidate (0.3 mg/kg).
Locations (1)
Peking University Shenzhen Hospital
Shenzhen, Guangdong, China